Huifang Dai
- Molecular Biology top 10%
- DNA Repair Mechanisms 9
- Epigenetics and DNA Methylation 5
- RNA modifications and cancer 5
- CRISPR and Genetic Engineering 3
- Cancer-related gene regulation 3
- Cancer Research top 10%
- Clinical Biochemistry top 10%
-
- Inflammatory Biomarkers in Disease Prognosis 2
-
- Liver Disease Diagnosis and Treatment 3
-
- Diet, Metabolism, and Disease 2
- Co-authors
- Binghui ShenLi ZhengMian ZhouQin HuangZhigang GuoJunzhuan QiuKemp H. KernstineDongxin Lin
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Huifang Dai
26 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 1.1k
- Cancer Research 180
- Clinical Biochemistry 59
- Oncology 210
- Aging 10
Countries citing papers authored by Huifang Dai
This map shows the geographic impact of Huifang Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huifang Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huifang Dai more than expected).
Fields of papers citing papers by Huifang Dai
This network shows the impact of papers produced by Huifang Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huifang Dai. The network helps show where Huifang Dai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huifang Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 8 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 14 | |
| 6 | 2022 | 6 | |
| 7 | 2020 | 8 | |
| 8 | 2017 | 32 | |
| 9 | 2016 | 16 | |
| 10 | 2016 | 66 | |
| 11 | 2015 | 26 | |
| 12 | 2014 | 4 | |
| 13 | 2013 | 128 | |
| 14 | 2011 | 41 | |
| 15 | 2011 | 16 | |
| 16 | 2010 | 113 | |
| 17 | 2008 | 104 | |
| 18 | 2008 | 182 | |
| 19 | 2007 | 202 | |
| 20 | 2004 | 15 |
About Huifang Dai
Huifang Dai is a scholar working on Aging, Biological Psychiatry and Nephrology, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (9 papers), Epigenetics and DNA Methylation (5 papers), RNA modifications and cancer (5 papers), Liver Disease Diagnosis and Treatment (3 papers), CRISPR and Genetic Engineering (3 papers), Cancer-related gene regulation (3 papers), Diet, Metabolism, and Disease (2 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). The work is most often cited by research in Molecular Biology (1.1k citations), Cancer Research (180 citations) and Clinical Biochemistry (59 citations). Huifang Dai has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Binghui Shen, Li Zheng, Mian Zhou, Qin Huang, Zhigang Guo, Junzhuan Qiu, Kemp H. Kernstine, Dongxin Lin, Purnima Singh and Limin Qian. Their work appears in journals such as Molecular and Cellular Biology, The EMBO Journal, Cancer, Scientific Reports and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.